Dean Andrew Rivers

Title: Dean Andrew Rivers: Innovator in Pharmaceutical Compounds

Introduction

Dean Andrew Rivers is a notable inventor based in Singapore, SG. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 3 patents, Rivers has focused on developing compounds that target specific biological pathways.

Latest Patents

One of his latest patents involves novel NADPH oxidase II inhibitors, which are crucial for the treatment of diseases mediated by NADPH oxidase enzymes. Another significant invention is related to oxadiazole substituted indazole derivatives, which serve as sphingosine 1-phosphate (S1P) agonists. This patent provides compounds with pharmacological activity, detailing processes for their preparation, pharmaceutical compositions, and their application in treating various disorders mediated by S1P1 receptors.

Career Highlights

Throughout his career, Dean Andrew Rivers has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Glaxo Group Limited and GlaxoSmithKline Intellectual Property Limited. His work in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Rivers has collaborated with several professionals in his field, including Mahmood Ahmed and James Myatt. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Dean Andrew Rivers stands out as an influential inventor in the pharmaceutical sector, with a focus on developing innovative compounds for medical applications. His contributions continue to impact the treatment of various diseases, showcasing the importance of innovation in healthcare.